Navigation Links
World Market for Biotechnology Reagents to Reach $32.5 Billion by 2012, According to New Report by Global Industry Analysts, Inc.
Date:11/13/2008

y activities. Product segments analyzed in the study include Cell/Tissue Culture Reagents, DNA Sequencing/Synthesis Reagents, Electrophoresis Reagents, Flow Cytometry Reagents, Immunoassay Reagents, Liquid Chromatography Reagents, Polymerase Chain Reaction Reagents, and Protein Synthesis Reagents. Analysis is presented for established and emerging markets including United States, Canada, Japan, France, Germany, United Kingdom, Italy, Asia-Pacific, and Latin America.

For more details of this research report, please visit
http://www.strategyr.com/Biotechnology_Reagents_Market_Report.asp

About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a reputed publisher of off-the-shelf market research. Founded in 1987, the company is globally recognized as one of the world's largest market research publishers. The company employs over 700 people worldwide and publishes more than 880 full-scale research reports each year. Additionally, the company also offers a range of over 60,000 smaller research products including company reports, market trend reports, and industry reports encompassing all major industries worldwide.

Global Industry Analysts, Inc.
Telephone 408-528-9966
Fax 408-528-9977
Email press@StrategyR.com
Web Site http://www.StrategyR.com/

###

Read the full story at http://www.prweb.com/releases/biotechnology_reagents/immunoassay_reagents/prweb1606644.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Page: 1 2 3

Related biology technology :

1. Pfizer and Bristol-Myers Squibb Finalize Agreement for Worldwide Collaboration on Metabolic Disorders Program
2. Evotec to Present Details of the Positive Phase II Study in Insomnia With EVT 201 at the Worldsleep07 Congress in Cairns/Australia
3. Avicena Signs Worldwide Exclusive Distribution Agreement with RITA Corporation for its Proprietary Dermaceutical Compounds
4. Safety Profile of TAXUS(R) Liberte(TM) Stent System Highlighted in Worlds Largest Stent Registry
5. CeloNova BioSciences Announces Worlds First Line of Fully Color-Coded Embolic Particles at CIRSE: Embozene(TM) Color-Advanced Microspheres
6. Stereotaxis Niobe System Used to Perform More Than 10,000 Procedures Worldwide
7. NexGenix Pharmaceuticals Enters into Exclusive World-wide License to Develop Novel Hsp90 Inhibitors
8. PATH, World Health Organization, and Partners Introduce Meningitis Vaccine in Burkina Faso
9. Doping technique brings nanomechanical devices into the semiconductor world
10. Advanced Instruments Introduces Worlds Fastest High Throughput Freezing Point Osmometer
11. Celebrities and Notables From the Worlds of Film, Television, Music and Sports Join Lifetime Televisions 13th Annual Multi-Platform Stop Breast Cancer For Life Campaign

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
World Market for Biotechnology Reagents to Reach $32.5 Billion by 2012, According to New Report by Global Industry Analysts, Inc.
World Market for Biotechnology Reagents to Reach $32.5 Billion by 2012, According to New Report by Global Industry Analysts, Inc.
(Date:12/1/2009)...s services to three out of top five ,global pharma...hester, NY (PRWEB) December 1, 2009 -- iCardiac Te...iac core lab services and QT analysis, announced t...lected iCardiac as a preferred vendor of ECG core ...ted QT(sm) and Dynamic QT beat-to-beat(sm) service...
(Date:11/30/2009)...re/ -- The Ohio Capital Fund today underscored its...siness early-stage capital summits. The event, to...forming the Landscape of Business in America: A Mi...ll feature several speakers including investors, n...ty entrepreneurs. ,, "The Ohio Capital Fund,s ...
(Date:11/30/2009)...swire/ -- Acuo Technologies, developers of high-pe...migration tools and services, today announced cont...w Vendor Neutral Archive (VNA), providing the foun...of hospitals, clinics and affiliates. ,, The ar... DICOM Services Grid(TM) Software. The Acuo VNA a...
(Date:11/30/2009)... 30 Good Publication Practice 2 (G...of company-sponsored medical research, has been pu...l (BMJ). "The publication of GPP2 in BMJ is strong...t and guidance for industry sponsored research and...ewed medical literature," said Chris Graf, Associa...
Breaking Biology Technology:Another Top Five Pharmaceutical Company Selects iCardiac as Preferred Provider of ECG Core Lab Services 2Ohio Capital Fund Announces Sponsorship of Minority Business Conference 2Acuo Technologies Announces Contract for Vendor Neutral Archive With Allina Hospitals and Clinics 2Acuo Technologies Announces Contract for Vendor Neutral Archive With Allina Hospitals and Clinics 3ISMPP Announces Publication of Good Publication Practice for Communicating Company-Sponsored Medical Research: GPP2 Guidelines Published in the BMJ 2ISMPP Announces Publication of Good Publication Practice for Communicating Company-Sponsored Medical Research: GPP2 Guidelines Published in the BMJ 3
...March 13 Trubion Pharmaceuticals,Inc. (Nasdaq: T...urth,quarter and year ended Dec. 31, 2007, as well...Year 2007 Financial Results, Revenue for the four...$6.4 million for the fourth quarter of 2006. Reven...lion compared with $36.5 million for the year,ende...
...., March 13 ViroPharma Incorporated,(Nasdaq: VPH...ancial officer,and chief operating officer of Viro...nnual Health Care Conference at 1:40 P.M. ET on Tu... at the Boston Marriott Copley,Place., ViroPharma... through, http://www.viropharma.com and available...
...elgium, March 13 ThromboGenics NV,(Euronext Bruss...ular,diseases, today announces a business update a...od ending 31 December 2007. During this period,Thr...n its development,pipeline and has continued to ma...hlights, - Successful placing of a total of 5,166...
Other Biology Technology:Trubion Pharmaceuticals Inc. Reports Fourth-Quarter and Year-Ended 2007 Financial Results and Provides 2008 Financial Outlook 2Trubion Pharmaceuticals Inc. Reports Fourth-Quarter and Year-Ended 2007 Financial Results and Provides 2008 Financial Outlook 3Trubion Pharmaceuticals Inc. Reports Fourth-Quarter and Year-Ended 2007 Financial Results and Provides 2008 Financial Outlook 4Trubion Pharmaceuticals Inc. Reports Fourth-Quarter and Year-Ended 2007 Financial Results and Provides 2008 Financial Outlook 5Trubion Pharmaceuticals Inc. Reports Fourth-Quarter and Year-Ended 2007 Financial Results and Provides 2008 Financial Outlook 6ThromboGenics Announces 2007 Full Year Results 2ThromboGenics Announces 2007 Full Year Results 3ThromboGenics Announces 2007 Full Year Results 4
(Date:11/30/2009)...he virus,s exquisite specialisation for its human ...like the humble lab mouse, can deliver only limite...in BioMed Central,s open access Journal of Biolog...by creating a mouse that has key features of HIV i...ge Kassiotis, from the Division of Immunoregulatio...
(Date:11/30/2009)...Nov. 30 Neurotechnology ( http://w...sion biometric identification technologies, has re...uct line: VeriLook 4.0 Software Development Kit ... SDK for large-scale multi-biometric and automated...ed capabilities in VeriLook 4.0 provide enhanced f...
(Date:11/26/2009)...red deer have been caught in the hunters, sights f... than decorative. They are lethal weapons that sta... The University of York, UK, has been intrigued by... century and has become fascinated by the mechanic...llaboration with Tomas Landete-Castillejos at the ...
Breaking Biology News(10 mins):A reductionist approach to HIV research 2New VeriLook 4.0 for Biometric Facial Recognition and MegaMatcher 3.1 for Multi-biometric Applications Are Now Available 2New VeriLook 4.0 for Biometric Facial Recognition and MegaMatcher 3.1 for Multi-biometric Applications Are Now Available 3Tough yet stiff deer antler is materials scientist's dream 2Leading Senior Care Destination TheCaringSpace com Launches ElderCare Library and Care Community 51670 1Leading Senior Care Destination TheCaringSpace com Launches ElderCare Library and Care Community 51670 2Healing Depression The Mind Body Way Aims to Depression Proof Your Life 51665 1Healing Depression The Mind Body Way Aims to Depression Proof Your Life 51665 2Stopping harmful oral bacteria in its path is goal for Case Western Reserve researcher 51661 1Stopping harmful oral bacteria in its path is goal for Case Western Reserve researcher 51661 2
...minds of volunteers preparing to play a brief visu...School of Medicine in St. Louis have found they ca...ail at the game. , "Before we present the task, w...percent accuracy whether the subject will give a c... Ayelet Sapir, Ph.D., a postdoctoral research asso...
... discovered that the activity of several embryonic...ast cancers, providing some of the first molecular...nd cancer. , The finding, reported in the November... a role in the development of tumors or serve as v...ers say. As such, the genes ultimately could lead ...
...hns Hopkins Kimmel Cancer Center have found that a...may provide a new way to treat autoimmune diseases...l cultures and mice suggest that blocking the path...known as FLT3, targets an immune system cell often...erapies. , FLT3, which controls the development o...
Other Biology News:Researchers use brain scans to predict behavior 2Study hints at role of stem cell genes in testicular, breast cancers 2Study hints at role of stem cell genes in testicular, breast cancers 3Study hints at role of stem cell genes in testicular, breast cancers 4Dendritic cells offer new therapeutic target for drugs to treat MS and other autoimmune disease 2
Rabbit Anti-hCG Polyclonal Antibody, Unconjugated from Abcam
Donkey Anti-Human Lactoferrin Antibody, Horseradish Peroxidase Conjugated from Biomeda Corporation
Rabbit Anti-EEF2K Monoclonal Antibody, Unconjugated, Clone EP881Y from Abcam
Rabbit Anti-ICAD Polyclonal Antibody, Unconjugated from BD Biosciences Pharmingen
Biology Products: